Food Funct (2012) 3:11619
Focusing narrowly on obesity, which affects some 40.3% of US adults, according to the CDCs 2021-2023 analysis, and costs the US economy more than $400 billion annually, the potential of GLP-1 drugs to address the obesity crisis could have a profound economic impact, Sandra Barbosu, associate director of the Information Technology & Innovation Foundations Center for Life Sciences Innovation, and Natalie Khoo, a student at Kings College London, write in an analysis titled A Shot at a Healthier Future: The Transformative Potential of GLP-1s
RZ: Data curation, Writing review & editing
They need a credible, ready-to-brand way to enter the skincare space, begin selling, and learn what their customers respond to
A critical ally for anyone focused on sustainable, healthy weight loss
This helps our providers determine the right GLP-1 medication for you